Research on disease-causing bacteria and how they spread. Covers waterborne bacteria, Lyme disease ecology, pathogenic genetics, and biofilm treatments.
This study provides evidence for pathogen-specific gene responses in dendritic cells, offering insights into the tailored immune defense mechanism. The research uses DNA array technology to investigate how dendritic cells discriminate between pathogens and activates specific genes to initiate an immune response.
Researchers at AgraQuest have developed a natural pesticide called Serenade that targets various fungal and bacterial diseases. It is highly effective and nontoxic to humans, birds, fish, and beneficial insects, making it suitable for integrated pest management systems.
Researchers at Ohio State University have developed a new DNA-based vaccine approach that successfully immunizes mice against anthrax. The vaccine uses combinations of two gene products produced by the bacteria responsible for causing anthrax, resulting in strong immune responses.
A bacterial peptide has been identified as a key regulator of host responses to infection. This discovery opens up new avenues for the development of therapies targeting this process.
Students at IIT's Interprofessional Program developed a blood sniffing e-nose that can identify hundreds of specific scent signatures, potentially cutting testing time down to minutes. The technology uses electronic noses sensitive to microscopic particles, similar to the receptors in the human nose.
Researchers have discovered that chemokine expression plays a crucial role in enhancing antibacterial immunity. This finding is significant for the development of novel therapeutic strategies against bacterial infections.
Researchers found that antibodies can convert oxygen into hydrogen peroxide, a previously unknown mechanism that could enhance their killing power and contribute to autoimmune diseases like lupus. This discovery opens up exciting possibilities for new antibody-mediated therapies for bacterial, viral, and cancer treatments.
Duke researchers have identified caveolae, small pits on cell membranes, as a route of entry for various pathogens and toxins. This finding could lead to new avenues for treating infections and delivering drugs into cells.
Ketek has been granted marketing authorisation by the European Commission for treating community-acquired respiratory tract infections, including those caused by resistant bacteria. The approval follows positive opinion from the Committee for Proprietary Medicinal Products and will be available in all 15 EU-Member States.
Researchers at Scripps Research Institute develop cyclic peptide nanotubes that disrupt bacterial cell walls, killing deadly pathogens. These 'nanotube' stacks have strong bactericidal activity and may minimize resistance development.
Researchers found that vegetable recipes from around the world are less spicy than their meat-based counterparts, thanks to plants' inherent defenses against bacterial and fungal infections. The study suggests that spices were originally used to protect against foodborne pathogens in hot climates before refrigeration.
The study suggests KETEK is an effective option for treating community-acquired respiratory tract infections, which cause 50 million deaths globally each year. KETEK demonstrated high activity against a range of bacteria, including pneumococci and S. pyogenes, with up to 99.6% susceptibility
Researchers found that Shigella bacteria can survive for up to six days in refrigerated conditions and rapidly multiply at room temperature. Properly storing fruits and vegetables and thoroughly washing them are crucial to removing pathogens like Shigella from produce.